Evidence map›Paper›PMID 40593538›Full record

ArticleNature communications2025

TUG protein acts through a disordered region to organize the early secretory pathway.

Anup Parchure, Helen Tejada, Zhiqun Xi, Yeongho Kim, Maohan Su, You Yan, Omar Julca-Zevallos, Abel R Alcázar-Román, Marie Villemeur, Xinran Liu and 3 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Anup ParchureSection of Endocrinology and Metabolism, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA. anupparchure@gmail.com.ORCID http://orcid.org/0000-0003-1452-799X
Helen TejadaSection of Endocrinology and Metabolism, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0009-0003-0382-5702
Zhiqun XiDepartment of Cell Biology, Yale School of Medicine, New Haven, CT, USA.
Yeongho KimDepartment of Cell Biology, Yale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-1477-925X
Maohan SuDepartment of Cell Biology, Yale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0001-5523-9607
Omar Julca-ZevallosSection of Endocrinology and Metabolism, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Abel R Alcázar-RománSection of Endocrinology and Metabolism, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Marie VillemeurUniversité Paris Cité, CNRS UMR7592, Institut Jacques Monod, Paris, France.
Xinran LiuDepartment of Cell Biology, Yale School of Medicine, New Haven, CT, USA.
Derek ToomreDepartment of Cell Biology, Yale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-6827-8127
Ishier RaoteUniversité Paris Cité, CNRS UMR7592, Institut Jacques Monod, Paris, France.ORCID http://orcid.org/0000-0002-5898-4896
Jonathan S BoganSection of Endocrinology and Metabolism, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA. jonathan.bogan@yale.edu.ORCID http://orcid.org/0000-0001-6463-8466

Funding

Yale Diabetes Research CenterP30DK045735 · NIDDK · YALE UNIVERSITY · PI GERALD I SHULMAN · 1993 to 2026
$44.0M
Development of a Versatile Multiplexing Nanoscopy Platform for Cell BiologyR01GM151829 · NIGMS · YALE UNIVERSITY · PI Joerg Bewersdorf · 2023 to 2026
$2.3M
Vesicle Translocation and the Metabolic SyndromeR01DK129466 · NIDDK · YALE UNIVERSITY · PI BOGAN, JONATHAN · 2022 to 2025
$2.0M
Integrin Trafficking to Focal AdhesionsR01GM134148 · NIGMS · YALE UNIVERSITY · PI CALDERWOOD, DAVID A, TOOMRE, DEREK K. · 2020 to 2023
$1.8M
Agence Nationale de la Recherche (French National Research Agency) MatSecFondation pour la Recherche Médicale (Foundation for Medical Research in France) AJE202210016216NIDDK NIH HHS P30 DK045735NIDDK NIH HHS R01 DK129466NIGMS NIH HHS R01 GM134148NIGMS NIH HHS R01 GM151829
6 · The paper itself

Abstract

The Endoplasmic Reticulum (ER)-Golgi Intermediate Compartment (ERGIC) is a network of tubules and vesicles known for producing COPI vesicles and receiving COPII vesicles from the ER. Much about its identity, stability, and regulation remains unknown. Here, we show that TUG (UBXN9, Aspscr1) protein, a central regulator of GLUT4 trafficking, localizes to the ERGIC, and that its deletion enhances anterograde flux of a model soluble cargo protein. TUG deletion redistributes ERGIC markers to the cis-Golgi and alters Golgi morphology. TUG forms biomolecular condensates in vitro and contains a central disordered region that mediates its recruitment to ERGIC membranes. A distinct N-terminal region mediates its oligomerization in cells. TUG deletion disrupts ERGIC-dependent processes, including autophagy and collagen secretion, and alters the targeting of the CFTR chloride channel. We conclude that TUG organizes and stabilizes ERGIC membranes to support their roles in diverse secretory and degradative membrane trafficking pathways.

Indexed as

Endoplasmic ReticulumSecretory PathwayAnimalsAutophagyCollagenCOP-Coated VesiclesCystic Fibrosis Transmembrane Conductance RegulatorGolgi ApparatusHumansMiceProtein TransportCollagenCystic Fibrosis Transmembrane Conductance Regulator

Identifiers

PMID40593538
PMCPMC12218103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.